PRESS-RELEASE ·Filed Jul 28, 2026
Press release: earnings
Actionable Insight • Neutral
Monitor the upcoming Q2 2026 earnings release on August 13 for revenue, EPS, and pipeline updates on rezpegaldesleukin. No immediate trading action is warranted from this filing.
Latest settled — T+20d
NKTR ▲ +4.37% at T+20d
NEUTRAL call ✓ call won +4.37% · α vs SPY -0.65% · entry $70.68 → $73.77
Latest observation: T+57 -48.48% FF3 residual α
T+1d
+1.09%
call +1.09% · α -0.59%
$71.45
settled 3mo ago
T+5d
+3.41%
call +3.41% · α -2.12%
$73.09
settled 3mo ago
T+20d
+4.37%
call +4.37% · α -0.65%
$73.77
settled 8w ago
T+60d
—
call — · α —
—
tomorrow
Price Chart
Loading chart...
Executive Summary
Nektar Therapeutics announced it will report Q2 2026 financial results on August 13, 2026. The filing is a routine earnings date announcement with no financial results or guidance provided, making it a non-event for traders.
Key Facts
- Nektar will report Q2 2026 results on August 13, 2026 after market close.
- No financial results, guidance, or material business updates were disclosed.
- The filing is a standard earnings date announcement with no actionable financial data.
Financial Impact
No financial data disclosed in this filing.
Risk Factors
- No new financial data to assess risk.
- Clinical-stage biotech pipeline risk remains unchanged.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302837015 |
14 reports for NKTR
100% Hit rate best @ T+20▲ +28.57%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 9w ago | Press Release | $73.02 $68.50 | ▼ −6.19% | ▼ −4.20% | $35.78 (−51.00%) |
Aug 9, 2026 10w ago | Institutional Cluster | $74.86 $75.44 | ▲ +0.77% | ▲ +1.69% | $35.78 (−52.20%) |
Aug 7, 2026 10w ago | Court Ruling | $76.48 $74.19 | ▼ −2.99% | ▼ −2.60% | $35.78 (−53.22%) |
Jul 28, 2026 11w ago | Press Release | $70.68 $73.77 | ▲ +4.37% | ▼ −0.65% | $35.78 (−49.38%) |
Jun 11, 2026 18w ago | Institutional Cluster | $59.21 $72.92 | ▲ +23.15% | ▲ +21.26% | $35.78 (−39.57%) |
Jun 11, 2026 18w ago | Institutional Cluster | $59.21 $72.92 | ▲ +23.15% | ▲ +21.26% | $35.78 (−39.57%) |
May 21, 2026 21w ago | Insider Cluster | $66.61 $65.25 | ▲ +2.04% | ▲ +0.63% | $35.78 (+46.28%) |
May 8, 2026 23w ago | 8-K | $78.72 $56.23 | ▲ +28.57% | ▲ +28.27% | $35.78 (+54.55%) |
May 7, 2026 23w ago | 8-K | $81.89 $57.32 | ▼ −30.00% | ▼ −30.03% | $35.78 (−56.31%) |
Apr 24, 2026 25w ago | DEFA14A | $86.74 $65.56 | ▼ −24.42% | ▼ −29.37% | $35.78 (−58.75%) |
Showing 10 of 14
US Market Status
Market Closed — Opens in 30m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access